Gujrathi Sheila

Director at VTYX; Chief Medical Officer at Receptos, Inc.

Sold, on record
$8.5M
Dollars the filings state
Form 4 sales
3
Latest Mar 30, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
2
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Receptos, Inc.Plan not stated
    Sep 22, 2014 2014

    Sold 30,000 shares at $61.45 ($1.8M)

    Gujrathi Sheila, Chief Medical Officer

    Sold 16.6% of holdings ($11.1M position)150,661 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Receptos, Inc.Plan not stated
    Nov 11, 2014 +50 days

    Sold 30,000 shares at $108.99 ($3.3M)

    Gujrathi Sheila, Chief Medical Officer

    Sold 19.9% of holdings ($16.4M position)120,661 shares leftFiling

  3. 3 Form 4 sale VTYXUnusual
    Mar 30, 2023 +3061 days

    Sold 100,000 shares at $33.73 ($3.4M)

    Gujrathi Sheila, Director

    No 10b5-1 planSold 100% of holdings ($3.4M position)0 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Gujrathi Sheila
Source
Mar 30, 2023Mar 31, 2023VTYXDirectorForm 4 sale100,000$3.4M100.0%UnusualSEC
Nov 11, 2014Nov 12, 2014Receptos, Inc.Chief Medical OfficerForm 4 sale30,000$3.3M19.9%Plan not statedSEC
Sep 22, 2014Sep 24, 2014Receptos, Inc.Chief Medical OfficerForm 4 sale30,000$1.8M16.6%Plan not statedSEC